Press Room
In The News in Bellevue and Seattle
We hope you will find these articles and press releases informative and interesting as you move along your journey with cosmetic surgery. Check back often for breaking news. Please direct media inquiries to [email protected].
Juvéderm® VOLUX™ XC, Gains FDA-Approval for Jawline Improvement
by Dr. Egrari
JUVÉDERM® VOLUX™ XC is the first and only hyaluronic acid (HA) filler to receive U.S. FDA approval for improving jawline definition. For adults over the age of 21 with moderate to severe jawline definition loss, this cutting-edge injectable represents the most significant leap in innovation for the JUVÉDERM® HA portfolio…
Read moreJuvéderm® Volbella® XC, Is Now The First And Only Dermal Filler To Receive FDA Approval For Use Under The Eyes
by Dr. Egrari
Volbella, one of the dermal fillers in the most popular dermal filler family, Juvederm, has now become FDA-approved for filling hollows and circles under the eyes. This is the latest news from Allergan Aesthetics, an AbbVie company. Clinical trials have shown that 90% of subjects were satisfied after one year following their treatment with Volbella for under-eye hollows…
Read moreAllergan Receives FDA Clearance For The Coolsculpting ® Treatment To Improve Appearance Of Lax Tissue In The Double Chin
by Dr. Egrari
Allergan plc (NYSE: AGN) today announced that the CoolSculpting® treatment is the first and only non-surgical fat reduction technology to be FDA-cleared for improved appearance of lax tissue in conjunction with submental fat, or double chin, treatments. CoolSculpting for the double chin is already clinically proven to reduce fat up to 20 percent in the treated…
Read moreMentor Receives FDA Approval For Mentor ® Memoryshape ™ Breast Implants
by Dr. Egrari
Newly Available Teardrop-Shaped Breast Implants Provide Natural Silhouette and Youthful Feel SANTA BARBARA, Calif., June 14, 2013 /PRNewswire/ — Mentor Worldwide LLC, the U.S. market leader in breast aesthetics, today announced the U.S. Food and Drug Administration (FDA) has approved MENTOR® MemoryShape™ Breast Implants, providing new options for women looking for a more natural shape…
Read moreBellevue Physician Promoting Living Skin Donation
by Dr. Egrari
Bellevue, WA — Obesity has become a national epidemic. Each year, across many different age groups, the number of overweight Americans has been on the rise. One of the most effective means of battling morbid obesity is Bariatric Surgery, which — in appropriate candidates — can dramatically reduce massive weight. However, along with such weight…
Read moreSilicone Breast Implants Approved With Conditions
by Dr. Egrari
Plastic Surgery Societies Applaud FDA Panel Recommendation That Mentor’s Silicone Breast Implants Be Approved With Conditions Gaithersburg, MD — The U.S. Food and Drug Administration advisory panel’s 7-2 vote today to recommend to the FDA that Mentor’s silicone breast implants be approved with conditions is applauded by the American Society of Plastic Surgeons (ASPS) and…
Read moreUnlicensed Raw Botulinum Toxin Source Of Patients Illness In Florida
by Dr. Egrari
ALLERGAN’S BOTOX® (BOTULINUM TOXIN TYPE A) NOT THE CAUSE OF BOTULISM IN FLORIDA PATIENTS — FDA Affadavit Identifies Unlicensed Raw Botulinum Toxin as Source of Patient’s Illnesses Irvine, CA — Allergan, Inc. (NYSE: AGN) announced today that a U.S. Food and Drug Administration (FDA) affidavit filed in the U.S. Federal District Court reveals that BOTOX®…
Read moreLeo & Jessica's Journey: One Year Later, 352 Pounds Lighter
by Dr. Egrari
Link to Seattle Times article, “Leo & Jessica’s Journey: One Year Later, 352 Pounds Lighter.” Dr. Egrari helped this couple with their post-weightloss body contouring.
Read moreSepehr Egrari Md Facs Offers Revolutionary New Wrinkle Treatment - Radiesse®
by Dr. Egrari
Revolutionary New Wrinkle Treatment — Radiesse® Healthy young skin contains collagen that gives it volume, flexibility and strength. As part of the aging process, your own natural collagen breaks down, diminishing facial volume. This loss of elasticity and volume results in the wrinkles, facial lines and skin laxity that rob your skin of its youthful…
Read moreFDA Advisory Panel Recommends Opening Market For Silicone Breast Implants
by Dr. Egrari
F.D.A. Panel Backs Silicone Breast Implants Gaithersburg, MD — After 11 years off the market, an advisory panel to the Food and Drug Administration has voted to recommend that silicone breast implants be allowed to be used in breast surgery. The FDA typically follows the recommendations of the advisory panel and expects to make a…
Read moreBreast Cancer Awareness Facts From The American Society Of Plastic Surgeons
by Dr. Egrari
National Breast Cancer Awareness Month Last year, more than 203,000 women were diagnosed with breast cancer. This year, an estimated 211,000 more will receive the same diagnosis. Because breast cancer is 90 percent curable when caught early, women need to know how important it is to perform regular self breast-exams. Losing a breast is both…
Read moreStatement From American Society Of Aesthetic Plastic Surgeons Regarding Fictional Portrayal Of Plastic Surgery In Tv Show "Nip/tuck"
by Dr. Egrari
Fictional Portrayal of Plastic Surgery Does More Than Miss the Mark New York, NY — “Nip/Tuck,” a fictional television series that focuses on the personal and professional lives of two plastic surgeons, does not even remotely portray the “real life” world of plastic surgery and does a disservice to millions of patients who benefit from…
Read moreBellevue Plastic Surgeons To Hold BOTOX® Event Benefiting Overlake Hispital Children's Service & Oncology Clinic
by Dr. Egrari
Bellevue Plastic Surgeons to Hold BOTOX® Event Benefiting Overlake Hospital Children’s Service & Oncology Clinic Bellevue, WA — Dr. Aysel Sanderson and Dr. Sepehr Egrari announced today that they will be conducting a two-day BOTOX® event December 6th & 7th in their offices, the proceeds of which will benefit children’s services and a state-of-the-art oncology…
Read moreJUVÉDERM VOLUMA™ XC
What is JUVÉDERM VOLUMA™ XC injectable gel?
JUVÉDERM VOLUMA™ XC injectable gel is the first and only filler FDA-approved to instantly add volume to the cheek area. It gives you a subtle lift, helping to restore contour and a more youthful profile, for up to 2 years, in patients over the age of 21. It’s different than JUVÉDERM® XC and works on a different area of the face. JUVÉDERM® XC smoothes out moderate to severe wrinkles and folds around the nose and mouth, like parentheses. JUVÉDERM VOLUMA™ XC, however, adds volume to the cheek area.
